Published in Ann Rheum Dis on November 01, 1996
Measurement of IgA-alpha 1-antitrypsin complex in rheumatoid arthritis: a question of specificity? Ann Rheum Dis (1997) 0.75
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum (1985) 2.68
Identification of a lymphocyte enzyme that catalyzes pentamer immunoglobulin M assembly. J Biol Chem (1981) 1.43
The relationship between the complex of immunoglobulin A and alpha-1-antitrypsin, its constituent components and the acute-phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or D-penicillamine. Br J Rheumatol (1987) 1.15
Radiographic damage in rheumatoid arthritis: description by nonlinear models. J Rheumatol (1992) 0.97
The effect of biological crystals and human serum on the rate of formation of crystals of monosodium urate monohydrate in vitro. Br J Rheumatol (1991) 0.95
The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res (1983) 5.41
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Detection of Australia antigen by means of immune adherence haemagglutination test. Vox Sang (1971) 2.88
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med (1995) 2.63
Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci U S A (1998) 2.37
Chronic inflammatory arthropathy associated with HTLV-I. Lancet (1989) 2.28
Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science (1991) 2.18
Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res (2000) 2.00
Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol (1999) 1.99
"Tuftsin": a natural phagocytosis stimulating peptide. Nature (1970) 1.88
Endophytic colonization and in planta nitrogen fixation by a Herbaspirillum sp. isolated from wild rice species. Appl Environ Microbiol (2001) 1.86
Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum (1995) 1.85
Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis. J Am Acad Dermatol (1990) 1.67
Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction. Am Heart J (2000) 1.66
Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol (1977) 1.62
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum (1999) 1.57
Complement and tumor immunology. Adv Cancer Res (1971) 1.57
Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. Arthritis Rheum (1988) 1.54
Distribution of patients with 2,8-dihydroxyadenine urolithiasis and adenine phosphoribosyltransferase deficiency in Japan. J Urol (1988) 1.53
Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. J Dermatol (1990) 1.48
Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts. Rheumatology (Oxford) (2003) 1.47
Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br J Dermatol (1997) 1.44
Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies. Hum Genet (1987) 1.43
Annular erythema associated with primary Sjögren syndrome: analysis of T cell subsets in cutaneous infiltrates. J Am Acad Dermatol (1989) 1.42
Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest (1987) 1.42
Impaired sweating as an exocrine manifestation in Sjögren's syndrome. Br J Dermatol (1995) 1.38
Radiation-induced erythema nodosum. Br J Dermatol (1999) 1.38
Cutaneous metastases from carcinoma of the cervix resemble acquired lymphangioma. J Am Acad Dermatol (1994) 1.38
Isolation and characterization of a complementary DNA expressing human U1 small nuclear ribonucleoprotein C polypeptide. J Immunol (1988) 1.37
Reduction of complement in Behçet's disease and drug allergy. Med Biol (1974) 1.36
Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen. Nucleic Acids Res (2001) 1.35
Changes in levels of mRNAs for cell wall-related enzymes in growing cotton fiber cells. Plant Cell Physiol (1997) 1.35
Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection. Microbiol Immunol (1996) 1.33
Particulate tyrosinase of human malignant melanoma. Solubilization, purification following trypsin treatment, and characterization. Eur J Biochem (1978) 1.32
Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation (1991) 1.32
Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease. Bull World Health Organ (1975) 1.29
Intralesional steroid-therapy-induced reduction of plasma interleukin-6 and improvement of cutaneous plasmacytosis. Dermatology (1995) 1.28
Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy. J Clin Immunol (1999) 1.28
Expressed sequence tags from cultured cells of rice (Oryza sativa L.) under stressed conditions: analysis of transcripts of genes engaged in ATP-generating pathways. Plant Mol Biol (1994) 1.27
Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J Immunol (1999) 1.26
Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol (2001) 1.26
Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol (1992) 1.24
Measurement of anti-double-stranded DNA antibodies in major immunoglobulin classes. J Immunol Methods (1979) 1.23
Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol (1996) 1.22
Immunological and immunohistochemical analysis of rheumatoid nodules. Ann Rheum Dis (1989) 1.22
The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum (2001) 1.20
Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H. Anesthesiology (1995) 1.20
Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest (1996) 1.19
The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J Immunol (2000) 1.19
Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol (1984) 1.18
Anti-sclerotic effect of transforming growth factor-beta antibody in a mouse model of bleomycin-induced scleroderma. Clin Immunol (1999) 1.18
A new complement inhibitor in guinea pig serum. Jpn J Exp Med (1969) 1.17
Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect Immun (1997) 1.15
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Ann Rheum Dis (2004) 1.14
Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium. Arthritis Rheum (1997) 1.13
Clinicopathologic study of a SNCA gene duplication patient with Parkinson disease and dementia. Neurology (2008) 1.12
Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthritis Rheum (1998) 1.12
Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha. Arthritis Rheum (1996) 1.11
The role of subchondral bone resorption pits in osteoarthritis: MMP production by cells derived from bone marrow. Osteoarthritis Cartilage (2005) 1.11
Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features. Arthritis Rheum (1991) 1.11
Survival of non-small cell lung cancer patients with postoperative recurrence at distant organs. Ann Thorac Cardiovasc Surg (2001) 1.10
Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. Osteoarthritis Cartilage (2003) 1.09
Fine epitope mapping of the human SS-B/La protein. Identification of a distinct autoepitope homologous to a viral gag polyprotein. J Clin Invest (1990) 1.08
The effects of Cu-chlorophyllin on the active site formation of each component of guinea-pig complement. Immunology (1969) 1.08
Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. J Clin Invest (1991) 1.07
Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med (2000) 1.07
Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Arch Dermatol Res (2000) 1.06
Fibrinolytic activity of skin suface lipids. Lancet (1971) 1.06
Antigenicity of reduced and alkylated Australia antigen. J Immunol (1974) 1.05
Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (2001) 1.04
Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica. Clin Diagn Lab Immunol (1999) 1.04
Electrokinetic behavior of intermediate cells in immune hemolysis. J Immunol (1972) 1.03
Effect of malnutrition and nutritional rehabilitation on tuberculin reactivity and complement level in rats. Immunology (1979) 1.03
Common characteristics of mutant adenine phosphoribosyltransferases from four separate Japanese families with 2,8-dihydroxyadenine urolithiasis associated with partial enzyme deficiencies. Hum Genet (1985) 1.03
Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.03
Spontaneous release of angiotensin converting enzyme and interleukin 1 beta from peripheral blood monocytes from patients with rheumatoid arthritis under a serum free condition. Ann Rheum Dis (1990) 1.02
Characteristics and isolation of the phagocytosis-stimulating peptide, tuftsin. Biochim Biophys Acta (1973) 1.02
[Cytotoxic factor in lymph node extract]. Saishin Igaku (1970) 1.02
CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers. Clin Cancer Res (2000) 1.02
A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer (1980) 1.01
RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol (1998) 1.01
Putrescine biosynthesis in mammalial cells: essential for DNA synthesis but not for mitosis. Biochem Biophys Res Commun (1977) 1.01
Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol (2004) 1.00
Differential effects of inhibition of polyamine biosynthesis on cell cycle traverse and structure of the prematurely condensed chromosomes of normal and transformed cells. J Cell Physiol (1979) 1.00
T-cell mediated inflammatory pathway in osteoarthritis. Osteoarthritis Cartilage (1999) 1.00
Surgical resection of solitary adrenal metastasis from esophageal carcinoma following esophagectomy. Dis Esophagus (2007) 1.00
Mast cell numbers in diffuse scleroderma. Arch Dermatol (1987) 1.00
Common T cell receptor clonotype in lacrimal glands and labial salivary glands from patients with Sjögren's syndrome. J Clin Invest (1996) 1.00
T cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells are markedly decreased, in rheumatoid synovial fluids. Arthritis Rheum (1987) 1.00
Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice. J Rheumatol (1999) 1.00
T-cell receptor in Sjögren's syndrome. Br J Rheumatol (1997) 1.00
An improved method for separation of the fourth component of complement and C4 inactivating substance. Jpn J Exp Med (1972) 0.99
Increased plasma interleukin-6 in cutaneous plasmacytoma: the effect of intralesional steroid therapy. Br J Dermatol (1997) 0.99
Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol (2001) 0.99
A case of idiopathic spinal epidural lipomatosis presented with radicular pain caused by compression with enlarged veins surrounding nerve roots. Acta Neurol Scand (2002) 0.99
Nitric oxide production and inducible nitric oxide synthase expression in systemic sclerosis. J Rheumatol (1998) 0.98